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Inhalational anesthesia and propofol-based total intravenous anesthesia (TIVA) are the two
most popular methods of general anesthesia with distinct characteristics that may affect
quality of recovery (QOR) differently. This study compared QOR after corrective lower limb
osteotomy between desflurane-based inhalational anesthesia and propofol-based TIVA.
Methods
Sixty-eight patients, ASA class I or II who underwent corrective lower limb osteotomy were
randomized to receive either desflurane anesthesia or propofol TIVA. The primary outcome
was quality of recovery 40 (QoR-40) questionnaire scores on postoperative day (POD) 1
and 2. Postoperative nausea scores, antiemetic requirements, and amount of opioid con-
sumption via intravenous patient-controlled analgesia (IV PCA) were assessed as second-
ary outcomes.
Results
Global QoR-40 scores on POD 1 (153.5 (140.3, 171.3) vs. 140.0 (120.0, 173.0), P = 0.056,
95% CI; -22.5, 0.2) and POD 2 (155.5 (146.8, 175.5) vs. 152.0 (134.0, 179.0), P = 0.209,
95% CI; -17.5, 3.9) were comparable between the two groups. Among the five dimensions
of QoR-40, physical independence scores were significantly higher in the TIVA group com-
pared to the Desflurane group on POD both 1 and 2. Nausea scores (0.0 (0.0, 0.0) vs. 1.0
(0.0, 3.5), P < 0.001) and number of patients requiring rescue antiemetics (0% vs. 15.2%, P
= 0.017) were significantly lower in the TIVA group at the post anesthesia care unit (PACU).
Although the number of bolus attempts between 0–24 h and the morphine equivalent dose
of analgesics administered via IV PCA between 12–24 h were significantly less in the TIVA
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group compared to the Desflurane group, there was no significant difference between
groups for the overall 48 h postoperative period.
Conclusions
Propofol-based TIVA did not improve global QoR-40 scores compared with desflurane-
based inhalational anesthesia. However, considering the better QoR-40 scores in the
domain of physical independence and less nausea in the early postoperative period, propo-
fol TIVA should be considered as a useful option in patients undergoing corrective lower
limb osteotomy.
Introduction
General anesthesia and surgery often cause discomfort in various aspects of the patient’s life.
Although usually not life-threatening, delayed recovery after surgery not only reduces patient
satisfaction, but is also undesirable in terms of efficient medical resource allocation and cost-
effectiveness [1]. As an essential part of the surgical procedure, method of anesthesia should
also be chosen and carefully planned to provide high-quality recovery and help patients return
to normal daily activities faster.
Inhalational anesthesia and propofol-based total intravenous anesthesia (TIVA) are the two
most used general anesthesia techniques. Previous studies that compared quality of recovery
(QOR) after surgery under general anesthesia with these two methods report inconsistent
results [2–8]. This may be due to the anesthetic agents having a varied degree of effects
depending on type of surgery and patient population, and amount of surgical stress and
inflammation [9–11].
Conventional methods used to assess postoperative recovery such as pain, vital signs, dura-
tion of hospital stay, morbidity and mortality are fragmentary, and are often not sufficient to
evaluate QOR in patients without significant pre-existing comorbidities [12]. On the other
hand, the quality of recovery 40 questionnaire (QoR-40) which was developed in 2000 is
widely used and has been validated as a suitable method of assessing postoperative QOR in
various types of surgeries and anesthesia techniques [13]. Such assessment tools can be espe-
cially useful in younger patient populations undergoing lower limb surgery where functional
recovery is of much importance. There is a growing demand of corrective lower limb surgical
procedures in patients that are young and physically active due to various reasons including
early stage osteoarthritis causing mild deformities and pain, and limb lengthening for leg
length discrepancy or idiopathic short stature [14,15]. These patients have a wide range of
expectations encompassing pain relief, physical ability, and psychological well-being [16]. This
study aimed to evaluate QOR between inhalational anesthesia with desflurane and TIVA with
propofol in patients undergoing corrective lower limb osteotomies. As secondary outcomes,
we also assessed postoperative analgesic requirements, nausea scores and antiemetic use after
surgery.
Materials and methods
Ethics approval and patient selection
The protocol of the present study was approved by the Institutional Review Board and Hospi-
tal Research Ethics Committee of Yonsei University Health System, Seoul, South Korea (#4-
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2016-0164) on 15 April 2016, and registered at http://clinicaltrials.gov (NCT02826902). Writ-
ten informed consent was obtained from all patients enrolled in this study, which was con-
ducted from September 2016 to November 2019. The study population consisted of adult
patients 19 years and older that underwent corrective lower limb osteotomy for either short
stature, leg length discrepancy, or osteoarthritis. Patients with known allergies to propofol,
heart disease (heart failure, myocardial infarction), previous major cardiovascular surgery,
decreased renal function, recent stroke, or cognitive disorders were excluded.
Interventions
Patients were randomly allocated to receive either desflurane anesthesia (Desflurane group) or
propofol-based TIVA (TIVA group) on the day before surgery in a 1:1 ratio using a computer-
generated random table generator by S. Shin. Due to significant differences in anesthetic tech-
nique, attending anesthesiologists were not able to be blinded to randomization. Patients and
investigators in charge of administrating QoR-40 questionnaires remained blinded to group
allocation. The investigator in charge of data analysis (S.H. Kim) remained blinded to group
allocation until the entire analysis was completed. All surgical procedures were performed by
one of two orthopaedic surgeons.
Conduct of the study
Upon arrival at the operating room, standard monitoring including pulse oximetry, non-inva-
sive blood pressure monitoring, electrocardiography, and bispectral index (BIS, VISTA Moni-
toring System, Aspect Medical Systems Inc., Norwood, MA, USA) monitoring were applied in
all patients. In the Desflurane group, general anesthesia was induced with 5 mg/kg thiopental
sodium and maintained with 4–7% desflurane and remifentanil infusion according to the
Minto model [17]. In the TIVA group, anesthesia was induced and maintained with propofol
and remifentanil using an effect-site target-controlled infusion pump (Orchestra Base Primea:
Fresenius Vial, Brezins, France) according to the Marsh model [18] (propofol) and Minto [17]
model (remifentanil). In all patients, the depth of general anesthesia was maintained at target
BIS values between 40 and 60. Rocuronium (0.6 mg/kg) was used before intubation in all
patients. Mechanical ventilation was performed with 8 ml/kg of tidal volume and respiratory
rates were adjusted to maintain the end tidal CO2 levels between 35 to 45 mmHg with 50%
oxygen/air mixture.
All patients received ramosetron 0.3 mg and fentanyl 1μg/kg at end of surgery. Concur-
rently, intravenous patient-controlled analgesia (IV PCA) consisting of fentanyl 0.2 μg/kg/ml
and ramosetron 0.3 mg (total volume including normal saline, 150 ml) was initiated at a 2 ml/
h (0.4 μg/kg/h) background infusion rate and 0.5 ml (0.1 μg/kg) on-demand bolus dose with a
15 min lockout time.
In addition to analgesics administrated via IV PCA, all patients were given 37.5 mg trama-
dol and 325 mg acetaminophen per oral twice daily as routine analgesic medications. Rescue
analgesics consisted of either IV tramadol, acetaminophen, or meperidine were administered
as needed.
Data collection
QOR was assessed by using the QoR-40 questionnaire [19] at three time-points: the day before
surgery, POD 1 and POD 2 in the evening on 7 pm. The QoR-40 is a 40-item questionnaire
that has been validated in a diverse group of patients [13,19] and is comprised of five dimen-
sions; physical comfort (12 items), emotional state (9 items), physical independence (5 items),
psychological support (7 items), and pain (7 items). Each item is graded on a five-point Likert
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scale, and global QoR-40 scores range from 40 (extremely poor QOR) to 200 (excellent QOR).
Nausea scores was evaluated at the PACU (highest score during the stay), POD 1 and POD 2
(same time point of QoR-40 assessment) using an 11-point verbal numerical rating scale
(VNRS) ranging from 0 = no nausea to 10 = worst imaginable nausea. The incidence of vomit-
ing and the amount of rescue antiemetics (metocloprimide 10mg or ramosetron 0.3mg) that
were administered upon patient request were also recorded. The cumulative amount of analge-
sics administered, and number of bolus attempts via IV PCA up to 48 h after surgery were
recorded and analyzed at 12h intervals. The number of patients requiring rescue analgesics up
to postoperative 48h were assessed and compared between groups. Intraoperative heart rate,
mean blood pressure, and BIS were recorded at baseline, 10 min after induction, cessation of
anesthetics, and at tracheal extubation. Response time was defined as time taken from cessa-
tion of anesthetics to clear verbal response from the patient. Total intraoperative remifentanil
dose was also recorded and compared between groups. Vital signs at the PACU were collected
at admission and discharge.
Statistical analysis
Sample size calculation was done under the hypothesis that a difference in global QoR-40
score of 10 or more between groups would be clinically significant. To obtain 90% power with
a significance level of 5% by independent t-test and allowing for a dropout rate of 10%, 38
patients per group were needed.
A statistical analysis plan was drafted and outlined in our study protocol and was signed off
before data analysis. Descriptive data are presented as median (interquartile range, IQR) for
continuous variables, and number (proportion) for categorical variables. Continuous variables
(e.g., QoR-40 questionnaire score, vital signs, time from cessation of anesthetics to verbal
response, total remifentanil dose, VNRS for nausea, analgesics consumption via IV PCA) were
checked for normality by using the Kolmogorov-Smirnov test, and analyzed by either the inde-
pendent t-test or Mann-Whitney U test as indicated. Fisher’s exact test was used for the analy-
sis of categorical variables such as the incidence of vomiting or use of antiemetics. Database
lock was done by the primary investigator prior to final analysis. All statistical analyses were
performed using SPSS Statistics version 25 (IBM Corp., Armonk, NY, USA).
Results
Patients and perioperative characteristics
The CONSORT (Consolidated Standards of Reporting Trials) flow diagram is shown in Fig 1.
Seventy-six patients were screened for eligibility, enrolled, and randomized to either the Des-
flurane group or the TIVA group. All randomized patients received surgery under allocated
method of anesthesia. During postoperative follow-up, 5 and 3 patients in the Desflurane
group and TIVA group, respectively, refused to further participate in completing the QoR-40
questionnaires and were dropped from the study. The remaining 68 patients (33 patients in
the Desflurane group and 35 in the TIVA group) that received anesthesia as allocated and
completed the QoR-40 questionnaires were included in the final analysis.
Patient characteristics are shown in Table 1. All demographic characteristics were similar
between the two groups. Patients underwent lower limb lengthening or high tibial osteotomy
due to either short stature, leg length discrepancy or osteoarthritis. The number of patients
that presented with any pain before surgery was comparable between the two groups, and the
preoperative VNRS pain scores in these patients ranged from 1 to 3. Intraoperative remifenta-
nil usage was significantly greater in the TIVA group compared to the Desflurane group (0.12
(0.10, 0.15) μg/kg/min vs. 0.05 (0.04, 0.07) μg/kg/min, P< 0.001). Response time after
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Fig 1. CONSORT flowchart of patient sample selection.
https://doi.org/10.1371/journal.pone.0247089.g001
Table 1. Patient characteristics.
Desflurane group (n = 33) TIVA group (n = 35)
Age (years) 40.0 (22.0, 53.5) 27.0 (22.0, 49.0)
Sex (male/female) 22/11 21/14
Height (cm) 163.6 (157.3, 173.5) 160.2 (156.8, 167.5)
Weight (kg) 65.0 (55.9, 73.0) 64.1 (55.0, 67.1)
BMI (kg/m2) 23.9 (21.8, 27.7) 23.8 (21.9, 27.1)
ASA physical status (I/II) 24/9 27/8
Etiology
Short stature 18 (54.5) 23 (65.7)
Leg length discrepancy 0 (0.0) 2 (5.7)
Osteoarthritis 15 (45.5) 10 (28.6)
Patients with preoperative pain 14 (42.4) 11 (31.4)
Type of operation
Lower limb lengthening 18 (54.5) 25 (71.4)
High tibial osteotomy 15 (45.5) 10 (28.6)
Surgeon who performed the operation (A/B) 18 (54.5) / 15 (45.5) 25 (71.4) / 10 (28.6)
Anesthesia duration (min) 230.0 (135.0, 277.5) 252.5 (141.0, 265.0)
Intraoperative fluid (mL) 750 (550, 990) 900 (650, 1150)
Intraoperative remifentanil dose (μg/kg/min) 0.05 (0.04, 0.07) 0.12 (0.10, 0.15)
Intraoperative propofol dose (mg) 1500.5 (1304.5, 2051.8)
Response time (min) 8.3 (7.0, 10.0) 13.0 (7.9, 17.5)
Data are presented as median (interquartile range) or number (proportion). TIVA, total intravenous anesthesia;
BMI, body mass index; ASA, American Society of Anesthesiologists; Response time, time from cessation of
anesthetics to verbal response from patient.
https://doi.org/10.1371/journal.pone.0247089.t001
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cessation of anesthetics was significantly prolonged in the TIVA group compared to the Des-
flurane group (13.0 (7.9, 17.5) min vs. 8.3 (7.0, 10.0) min, P = 0.028). Perioperative vital signs
are shown in Fig 2. Heart rate was significantly higher in the Desflurane group at tracheal extu-
bation (73.0 (63.0, 82.0) bpm vs. 85.0 (75.0, 92.5) bpm, P = 0.001), and mean blood pressure
was significantly lower in the Desflurane group at 10 min after induction (73.7 (69.3, 81.0)
mmHg vs. 70.0 (66.2, 75.7) mmHg, P = 0.043).
None of the patients experienced complications related to anesthesia. One patient in each
group received correction surgery due to pin breakage and 3 patients in each group reported
hypoesthesia in toes, feet, or heel at 2 months after surgery. Three and two patients experi-
enced operative site infection and were treated with antibiotics in the Desflurane and TIVA
group, respectively (P = 0.472).
Quality of recovery and postoperative nausea and vomiting
Global scores and scores across the five different dimensions of the QoR-40 questionnaire are
shown in Table 2. Although not statistically significant, an 11.1-point difference in mean global
QoR-40 scores between groups was observed on POD 1 (153.5 (140.3, 171.3) vs. 140.0 (120.0,
173.0), P = 0.056, 95% CI; -22.5, 0.2). Global QoR-40 scores on POD 2 were comparable between
the two groups (155.5 (146.8, 175.5) vs. 152.0 (134.0, 179.0), P = 0.209, 95% CI; -17.5, 3.9).
Among the individual domains, the score for physical independence was significantly higher in
the TIVA group compared to the Desflurane group both on POD 1 and 2. Other QoR-40 scores
for individual domains were comparable between the two groups at all three time-points. In a
single question assessing the presence of severe pain (Have you had severe pain in the last 24
hours?), the score was higher in the TIVA group compared to the Desflurane group on both
POD 1 (3.0 (3.0, 4.0) vs. 3.0 (2.0, 3.0), P = 0.004) and 2 (4.0 (3.0, 4.0) vs. 3.0 (2.0, 3.5), P = 0.017).
Nausea scores were significantly lower in the TIVA group compared to the Desflurane
group at the PACU. (0.0 (0.0, 0.0) vs. 1.0 (0.0, 3.5), P< 0.001). None of the patients of the
TIVA group required antiemetics at the PACU while 5 (15.2%) patients received rescue anti-
emetics in the Desflurane group (P = 0.017). There was no difference in PONV or the use of
rescue antiemetics between groups during POD 1 and POD 2 (Table 3).
Fig 2. Perioperative (A) heart rate (beates/min) and (B) mean blood pressure (mmHg) of the Desflurane and TIVA group at six perioperative time-points; 1: at
baseline before induction, 2: 10 min after anesthesia induction, 3: at cessation of anesthetics, 4: at tracheal extubation, 5: admission to post anesthesia care unit
(PACU), 6: discharge from PACU. �P< 0.05 between two groups.
https://doi.org/10.1371/journal.pone.0247089.g002
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Table 2. QoR-40 scores preoperatively and on postoperative days 1 and 2.
Desflurane group (n = 33) TIVA group (n = 35) P value
Preoperative
Emotional status 36.0 (29.0, 38.0) 34.0 (31.8, 39.3) 0.904
Physical comfort 50.0 (46.0, 57.0) 51.5 (44.5, 55.3) 0.694
Psychological support 30.0 (24.0, 32.0) 26.5 (24.8, 29.8) 0.649
Physical independence 24.0 (22.0, 25.0) 24.0 (21.8, 25.0) 0.653
Pain 26.0 (23.0, 33.0) 30.0 (22.8, 34.3) 0.113
Global QoR-40 167.0 (147.0, 178.0) 164.5 (150.5, 174.0) 0.578
POD 1
Emotional status 33.0 (27.0, 42.0) 36.0 (31.0, 40.0) 0.100
Physical comfort 44.0 (36.0, 53.0) 44.5 (37.0, 52.0) 0.102
Psychological support 28.0 (25.0, 32.0) 27.0 (26.0, 29.0) 0.203
Physical independence 19.0 (14.0, 23.0) 20.5 (19.8, 24.0) 0.045
Pain 23.0 (20.0, 28.0) 26.0 (21.8, 28.3) 0.075
Global QoR-40 140.0 (120.0, 173.0) 153.5 (140.3, 171.3) 0.056
POD 2
Emotional status 37.0 (30.0, 41.0) 36.5 (32.0, 41.3) 0.524
Physical comfort 48.0 (40.0, 56.0) 48.0 (43.3, 52.5) 0.551
Psychological support 28.0 (26.0, 33.0) 27.5 (25.8, 29.0) 0.367
Physical independence 19.0 (14.0, 21.0) 21.0 (18.8, 25.0) 0.033
Pain 25.0 (20.0, 26.0) 25.0 (21.8, 29.0) 0.085
Global QoR-40 152.0 (134.0, 179.0) 155.5 (146.8, 175.5) 0.209
Data are presented as median (interquartile range). TIVA, total intravenous anesthesia; QoR-40, quality of recovery-40; POD, postoperative day.
https://doi.org/10.1371/journal.pone.0247089.t002
Table 3. Postoperative nausea and vomiting.
Desflurane group (n = 33) TIVA group (n = 35) P value
PACU
Nausea (VNRS) 1.0 (0.0, 3.5) 0.0 (0.0, 0.0) < 0.001
Vomiting/retching 2 (6.1%) 0 (0.0%) 0.232
Use of rescue antiemetics 5 (15.2%) 0 (0.0%) 0.017
Postoperative period
Nausea (VNRS)
POD 1 2.0 (0.0, 4.0) 1.0 (0.0, 2.0) 0.094
POD 2 1.0 (0.0, 2.5) 0.0 (0.0, 2.0) 0.116
Vomiting/retching
POD 1 4 (12.1%) 4 (11.4%) > 0.999
POD 2 0 (0%) 0 (0%) > 0.999
Use of rescue antiemetics
POD 1 2 (6.1%) 4 (11.4%) 0.674
POD 2 0 (0%) 1 (2.9%) > 0.999
Data are presented as median (interquartile range) or number (proportion). TIVA, total intravenous anesthesia;
VNRS, verbal numerical rating scale; POD, postoperative day.
https://doi.org/10.1371/journal.pone.0247089.t003
PLOS ONE Quality of recovery and anesthesia technique
PLOS ONE | https://doi.org/10.1371/journal.pone.0247089 February 19, 2021 7 / 13
Analgesics administration with intravenous PCA and rescue analgesics
requirements
Although the morphine equivalent dose (mg) infused via IV PCA was smaller in TIVA group
compared to Desflurane group during the postoperative 12–24 h interval, the overall dose used
up to postoperative 48 h was comparable between the two groups (132.1 (108.7, 153.9) vs.
144.1 (126.0, 163.0), P = 0.235). Similarly, the number of bolus attempts were significantly
smaller in the TIVA group compared to the Desflurane group at postoperative 0–12 h and 12–
24 h periods but comparable for the overall postoperative 48 h (Table 4). There was no differ-
ence between groups in the amount of rescue analgesics administered up to 48 h after surgery.
Discussion
While inhalational anesthesia is the most used and conventional method of general anesthesia,
the popularity of propofol-based intravenous anesthesia has grown in recent years. Behind this
growing interest are several reasons, one of which is the possibility that TIVA is able to
increase patients’ satisfaction after surgery under general anesthesia [20]. In the current study,
we found that global QoR-40 scores were not influenced by type of general anesthesia after
corrective lower limb osteotomy. However, among the five subdimensions of the QoR-40
questionnaire, TIVA was found to improve postoperative physical independence compared to
desflurane anesthesia. Although scores of the subdimension of pain in the QoR-40 question-
naire was not different, patients of the TIVA group made fewer bolus attempts via IV PCA
compared to the patients of the Desflurane group without any difference in additional rescue
analgesics administration. TIVA was also able to significantly decrease nausea scores and res-
cue antiemetic requirements at the PACU.
QOR after surgery goes beyond the traditional analysis of morbidity and mortality, and the
importance of patient-reported outcome measures are being increasingly recognized [21]. The
QoR-40 scale is among the most extensively studied scoring systems that provide a quantitative
measure of QOR after surgery and anesthesia [13]. We found global QoR-40 scores on POD 1
to be higher in the TIVA group compared to the Desflurane group, but the difference did not
reach statistical significance. However, the difference in means between groups is 11.1, which
exceeds the minimal clinically important difference (MCID) for the QoR-40. MCID is defined
Table 4. Data on intravenous patient-controlled analgesia.
Desflurane group (n = 33) TIVA group (n = 35) P value
Morphine equivalent dose (mg)
0–12 h 41.0 (36.9, 46.4) 36.9 (29.0, 43.8) 0.085
12–24 h 38.0 (33.2, 43.6) 32.8 (27.4, 40.1) 0.029
24–36 h 32.7 (28.5, 38.2) 31.4 (25.3, 38.5) 0.724
36–48 h 33.3 (26.9, 37.8) 32.2 (25.1, 36.9) 0.545
0–48 h 144.1 (126.0, 163.0) 132.1 (108.7, 153.9) 0.235
Bolus attempts
0–12 h 18.5 (9.8, 27.3) 12.0 (3.0, 20.0) 0.024
12–24 h 11.0 (5.8, 16.0) 5.0 (0.0, 12.0) 0.010
24–36 h 5.0 (0.8, 8.3) 7.0 (0.0, 10.0) 0.690
36–48 h 4.0 (0.0, 8.5) 3.0 (0.0, 10.0) 0.529
0–48 h 43.5 (25.8, 56.5) 28.0 (8.0, 50.0) 0.056
Data are presented as median (interquartile range). TIVA, total intravenous anesthesia.
https://doi.org/10.1371/journal.pone.0247089.t004
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as the smallest change in score that reflects a meaningful change in health status, and perioper-
ative interventions that result in change of 6.3 or more in QoR-40 scores signify a clinically
important improvement or deterioration [22]. Moreover, the better outcome in the dimension
of physical independence on POD 1 and 2 in the TIVA group is meaningful in that this score
can be associated with early resumption of daily activities [19] which in turn may possibly pre-
dict better long-term quality of life [23]. The dimension of physical independence includes
abilities to return to work, write, speak, wash, and look after one’s own appearance. These
results are significant, considering the growing interest in early recovery after surgery [24]
and the importance of early mobilization and functional recovery after orthopaedic surgery
[25–27].
It is noteworthy that the preoperative global QoR-40 scores in our study population were
somewhat lower than that reported in a previous study based on patients undergoing thyroid-
ectomy for thyroid neoplasms [2]. This may seem counterintuitive considering the relatively
younger and physically healthier patient population of our study. However, reasons for under-
going corrective lower limb osteotomy varies from occupational need, family opinion, peer
pressure, ability to do certain sports or activities, and psychological mood [28,29]. The need to
improve everyday function, reduce pain, and also improve psychological well-being through
surgical correction are important components of the expectations that patients may have
before undergoing corrective osteotomies. For patient populations that share similar aspects in
terms of the patients’ expectations and general sense of well-being, the results of the present
study may be able to shed some light on the perioperative management of such patients.
One well-known advantage of using propofol TIVA over inhalational anesthesia is the abil-
ity of propofol to reduce PONV [20,30,31]. Nausea, vomiting, and retching is included in the
dimension of physical comfort of QoR-40, where ease of breathing, ability to have good sleep
and enjoy food, feeling rested or restless, presence of shaking, twitching or shivering, and feel-
ing too cold or dizzy are also included. However, the outcomes of this dimension in previous
studies that compared propofol-based TIVA and inhalational anesthetics are inconsistent [2–
8], and we were not able to find any improvement in scores with TIVA in our study. Although
VNRS scores for nausea were found to be significantly lower in the TIVA group compared to
the Desflurane group at the PACU, there was no difference in nausea scores, incidence of vom-
iting/retching, or the use of antiemetics on POD 1 and 2. These results are similar to previous
studies where the antiemetic effect of propofol TIVA was found to be limited to the early post-
operative period [32,33].
In terms of the dimension of pain, we were not able to see a significant difference between
the two groups throughout the study. However, in a single question assessing the presence of
severe pain, the score was higher in the TIVA group compared to the Desflurane group on
both POD 1. In the same vein, a larger dose of analgesics via IV PCA was required during post-
operative 12–24 h, and a significantly greater number of bolus attempts during postoperative
0–12 h and 12–24 h were observed in the Desflurane group compared to the TIVA group. The
dimension of pain of the QoR-40 questionnaire not only includes surgical site pain, but also
pain in extrasurgical sites such as headache, muscle pains, backache, sore throat, and sore
mouth. The patient’s perception of “severe pain” and the use of analgesics to alleviate such
pain may not align with the scores in the dimension of pain in QoR-40, and therefore, the
results of the present study should be interpreted with caution. It should be noted however,
that in previous studies, propofol-based TIVA was found to improve postoperative pain com-
pared to inhalational anesthesia [20,31].
Compared to inhalational anesthetics, propofol has been shown to suppress the neuroendo-
crine stress response and reduce the release of catecholamines and cortisol during the periop-
erative period [34]. Propofol was also found to inhibit the release of pro-inflammatory
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cytokines, improve anti-inflammatory cytokine release and attenuate hyperglycemia during
surgery [35,36]. The favorable results seen in the TIVA group of the present study may be
attributable to these aforementioned characteristics of propofol.
There are several limitations to this study. First, sample size calculation was based on the
difference of the global QoR-40 scores, and therefore was not sufficient to determine the differ-
ence in individual domains of the questionnaire. Second, we did not include long-term func-
tional outcome or quality of life as outcomes in this study. While early postoperative QOR
may be related to quality of life several months after surgery [23], we were not able to confirm
this. Third, the patients enrolled in our study was relatively young and healthy and therefore it
is difficult to generalize our results to a broader patient population undergoing surgery that
may not share similar characteristics.
Conclusions
In conclusion, we did not find any difference in global QoR-40 scores after corrective lower
limb osteotomies between desflurane-based inhalational anesthesia and propofol-based TIVA.
The more favorable scores in the dimension of physical independence in the TIVA group may
suggest the possibility of better quality of life and resumption of daily activities in the early
postoperative period [24–27]. The lesser presence of severe pain and the fewer PCA rescue
bolus attempts may reflect a superior analgesic effect of TIVA compared to desflurane anesthe-
sia. This together with its confirmed antiemetic effects in the early postoperative period, pro-
pofol TIVA should be considered as a useful component of anesthetic management in patients
undergoing corrective lower limb osteotomies.
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